Regeneron Pharmaceuticals, Inc. published a marketing authorization application (MAA) to the European Medicines Agency (EMA) for the treatment of elderly patients with relapsed/refractory (R/R) multiple myeloma (MM).
The UK is now participating in an international clinical trial where cancer patients will receive a new treatment to help them identify and fight cancer cells. The first recipients of this experimental mRNA therapy.
To ensure a smooth transition for accredited laboratories, the National Accreditation Board for Laboratories (NABL) has announced that it will extend the transition period for certified laboratories from the original deadline of 31 December
Edwards Life Sciences Corporation, a global leader in patient-centered innovation for cardiovascular design and critical care monitoring, announced that the company's Evoque tricuspid valve replacement system is the first percutaneous therapy approve
Scientists at the University of Virginia (UVA) have developed a new approach to machine learning, a form of artificial intelligence, to identify drugs that can help reduce the severity of post-traumatic stress disorder, heart or other injuries.
Eton Pharmaceuticals, an innovative pharmaceutical company focused on developing, selling and commercializing products to address the unmet needs of patients with rare diseases
EDAP TMS SA, the worldwide innovator in automated energy-based treatments, reported that it has finished enlistment in its stage 3 review (Endo-HIFU-R2) assessing Central One Extreme focus Centered Ultrasound (HIFU) treatment for the treatment...
Torrent Pharmaceuticals reported a roughly 57% increase in third-quarter profit, driven by robust demand in the home market, Germany, and Brazil. The drugmaker's overall net profit for the quarter ended December 31 was ₹443 crore, up from ₹283...
Worldwide pharma significant Lupin Restricted (Lupin) reported that it has gotten endorsement from the US Food and Medication Organization (FDA) for its Truncated New Medication Application for dronedarone tablets USP, 400 mg, to showcase a...
Benuvia Operations, LLC, a U.S.-based drug developer and manufacturer of active pharmaceutical ingredients (APIs) with specialized expertise in controlled substances (cannabinoids and psychedelics), and Societal CDMO, Inc., a contract development...
, CDSCO.jpg)
.jpg)